Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan
about
H pylori antibiotic resistance: prevalence, importance, and advances in testingSecond and third line treatment options for Helicobacter pylori eradicationInhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori.Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.'Rescue' therapies for the management of Helicobacter pylori infection.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.Low Helicobacter pylori primary resistance to clarithromycin in gastric biopsy specimens from dyspeptic patients of a city in the interior of São Paulo, BrazilGeneration of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunityHigh-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients.Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population.Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.Effective regimens for the treatment of Helicobacter pylori infection.Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.Review article: the global emergence of Helicobacter pylori antibiotic resistance.Antisecretory Action of the Extract of the Aerial Parts of Eremomastax speciosa (Acanthaceae) Occurs through Antihistaminic and Anticholinergic Pathways.A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens.Antibiotic susceptibility, heteroresistance, and updated treatment strategies in Helicobacter pylori infection.Effect of glycine on Helicobacter pylori in vitro.The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.Helicobacter pylori and antibiotic resistance.In vitro and in vivo anti-Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha.Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.Emergence of clarithromycin-resistant Helicobacter pylori (CRHP) with a high prevalence in children compared with their parents.The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001).Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing.Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
P2860
Q24685864-23426DF7-2717-4C58-BD90-59FE22F9B29DQ26829666-23529DF9-6667-4FCF-8AE6-A28E47ABD571Q30680936-1E454039-E3F3-4DB8-A56D-36BD5B844F8DQ32026744-B465E103-72EF-4F63-9E71-7FA275A083C0Q33371187-48EF9147-8858-49F9-AE89-2F920C037F77Q33639114-E1480148-56C3-40A9-B509-D23C83144FEFQ34208298-7BECB6E7-7C41-4E28-A8F5-46A508E3F090Q34530327-734A198C-7F6C-46C8-B5F2-C5218086D11EQ34531903-BD23471B-FF1E-4A79-9D4C-A8BACA7C2C02Q34570815-0DE56236-802B-4D29-94BF-99A817B1F975Q34582242-8F717405-E7B0-4099-AECB-C3B33EC79E69Q35102928-D65ED69B-573C-45BA-99BE-187078192DE5Q35619151-2E053B46-1B34-4FD7-99BC-97523CEF384CQ35635843-91524A2C-F3D2-4D3D-8141-064EABEFB953Q36314577-184B0BC5-673E-4CB9-87B5-3996E1F51DDDQ36568724-585372AB-CAE6-4D6D-BE1C-0B9F181BE29AQ37087009-561FC78D-350A-4DC8-8A97-CD3CA2BB9C01Q37292037-70D95D9F-A74F-4E79-AF71-512CEB06EFB9Q37340339-C6ACADC2-7090-47B9-9E8F-FC13C0546D70Q37631767-058FA58C-2391-431F-A888-0717F824CC04Q37697753-3041A174-4DA9-4D2A-A90F-B52DF8099D33Q38320799-DD053044-4532-40CB-AB2E-84EC3FC20D1FQ38621376-7AF0B7FE-BA95-4DDF-A45D-B7F4FAE7D9E8Q40165615-91734449-595D-451C-913B-C86F8884087FQ40626311-E55D1CCB-29FF-4FF5-B679-39BC42475A7AQ42033124-862EF600-3E94-4498-BBBF-CB7E7D5324A4Q42249380-6600B5AB-6557-46B1-A7B4-7567A895B958Q42274547-A1A3C44D-3ACA-41A7-AFC8-A761599325AFQ42735860-53A912BE-C049-49A4-9DA7-94697E0D8926Q42964422-B5F01390-70D1-4CDC-86DE-9D983F44E124Q43591822-F9D4926F-E99E-431A-84D9-0A9B21916066Q43708032-86C6E11E-94C8-41D3-B585-1667276A06B2Q43782572-BB4D1BDD-8BE6-4A86-B7CC-DB035CA230D6Q43892519-D4083D8E-53E4-48C1-A832-6B402FE2E3E4Q44186926-BD5941AF-FF9B-4A7D-8597-C99F6E677B89Q44186938-8C71CCBB-B4C0-4CBB-A911-D6B616554226Q44444680-54261B15-9D26-41F8-988F-71905F4C2818Q44488914-73304332-D39F-49B6-B596-752DF51789E4Q51804069-718F6667-0DB7-49B8-B108-5A0F9CF6B049Q53406185-54ED8D10-70D6-40D4-A040-EE445944B695
P2860
Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Regional differences in metron ...... ter pylori isolates from Japan
@ast
Regional differences in metron ...... ter pylori isolates from Japan
@en
type
label
Regional differences in metron ...... ter pylori isolates from Japan
@ast
Regional differences in metron ...... ter pylori isolates from Japan
@en
prefLabel
Regional differences in metron ...... ter pylori isolates from Japan
@ast
Regional differences in metron ...... ter pylori isolates from Japan
@en
P2093
P2860
P1476
Regional differences in metron ...... ter pylori isolates from Japan
@en
P2093
El-Zaatari FA
P2860
P304
P356
10.1128/AAC.44.8.2214-2216.2000
P407
P577
2000-08-01T00:00:00Z